Literature DB >> 22500051

Overcoming "aspirin resistance" in MPN.

Ayalew Tefferi1.   

Abstract

In this issue of Blood, Pascale and colleagues show that biochemical resistance to aspirin in patients with essential thrombocythemia (ET) can be reversed by twice daily dosing.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22500051     DOI： 10.1182/blood-2012-02-406645

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  2 in total

Review 1.  Platelets Contribution to Thrombin Generation in Philadelphia-Negative Myeloproliferative Neoplasms: The "Circulating Wound" Model.

Authors:  Alessandro Lucchesi; Roberta Napolitano; Maria Teresa Bochicchio; Giulio Giordano; Mariasanta Napolitano
Journal:  Int J Mol Sci       Date:  2021-10-20       Impact factor: 5.923

Review 2.  Personalized management of essential thrombocythemia-application of recent evidence to clinical practice.

Authors:  A Tefferi; T Barbui
Journal:  Leukemia       Date:  2013-04-05       Impact factor: 11.528
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.